Clinical trial
Comparison of Keppra and Clonidine in the Treatment of Tics
NCT00370838 · Harvey S. Singer, Other · Completed
Key facts
| NCT number | NCT00370838 |
|---|---|
| Title | Comparison of Keppra and Clonidine in the Treatment of Tics |
| Official title | Comparison of Keppra and Clonidine in the Treatment of Tics in Children With Tourette Syndrome |
| Lead sponsor | Harvey S. Singer, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tic Disorders, Tourette Syndrome |
| Intervention type | Drug |
| Interventions | Levetiracetam, Clonidine |
| Enrollment | 12 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Sep 1, 2006 |
| Last update posted | Sep 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: